0.15% -0.015

Transcode Therapeutics Inc (RNAZ)

Panoramica Notizia Cronologia dei prezzi Financials Perché RNAZ Giù? Forum Previsione Frazionamento azionario

Transcode Therapeutics Inc Azioni (RNAZ) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-09-30	2025-06-30	2025-03-31	2024-06-30	2024-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	8.06% 4.5612	4.2211	3.1712	5.1139	3.289
Operating Income/Loss	8.06% -4.5612	-4.2211	-3.1712	-5.1139	-3.289
Nonoperating Income/Loss	432.53% -0.2949	-0.0554	-8.9142	-0.0769	-0.0378
Income/Loss From Continuing Operations Before Tax	13.55% -4.8561	-4.2765	-12.09	-5.1908	-3.3268
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	13.55% -4.8561	-4.2765	-12.09	-5.1908	-3.3268
Net Income/Loss	13.55% -4.8561	-4.2765	-12.09	-5.1908	-3.3268
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.00% 0.8337	0.8337	4.8233	7.0511	5.1424
Diluted Average Shares	0.00% 0.8337	0.8337	4.8233	7.0511	5.1424
Basic Earnings Per Share	13.45% -5.82	-5.13	-2.51	-0.74	-0.65
Diluted Earnings Per Share	13.45% -5.82	-5.13	-2.51	-0.74	-0.65
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%